Patel Nishant, Chastain Cody
Infectious Diseases, Vanderbilt University Medical Center, Nashville, USA.
Cureus. 2024 Feb 1;16(2):e53410. doi: 10.7759/cureus.53410. eCollection 2024 Feb.
Immune reconstitution inflammatory syndrome (IRIS) following initiation of antiretroviral therapy (ART) has variable incidence but is not uncommon and has the potential to cause long-term consequences and fatal outcomes in patients with HIV. Hemophagocytic lymphohistiocytosis (HLH) is a separate syndrome of excess immune activation, but may coexist with IRIS and necessitate a unique treatment approach. In this report, the case of a patient with newly diagnosed HIV/AIDS who was found to have both mycobacterial IRIS and HLH is presented.
抗逆转录病毒疗法(ART)启动后发生的免疫重建炎症综合征(IRIS)发病率不一,但并不罕见,有可能给HIV患者带来长期后果和致命结局。噬血细胞性淋巴组织细胞增生症(HLH)是一种免疫激活过度的独立综合征,但可能与IRIS并存,需要采取独特的治疗方法。在本报告中,介绍了一名新诊断为HIV/AIDS的患者,该患者同时患有分枝杆菌性IRIS和HLH。